Impact of Depression and Antidepressant Usage on the Clinical Outcomes of Chronic Liver Disease

Oct-19

Hepatology Mental Health Pharmacoepidemiology

AUTHORS : Dr Abdel Aziz Shaheen, Department of Medicine and Community Health Sciences, Division of Gastroenterology and Hepatology, O’Brien Institute for Public Health, Cumming School of Medicine, University of Calgary, 3280 Hospital Drive NW, Room 6D25, Calgary, Alberta T2N 4Z6, Canada – Email: aashahee@ucalgary.ca – Profile: http://www.ucalgary.ca/communityhealthsciences_info/profiles/1-7523637

JOURNAL : Hepatology

REFERENCE: 70(S1):451A-452A

DOI : 10.1002/hep.30941

Impact of Depression and Antidepressant Usage on the Clinical Outcomes of Chronic Liver Disease

More publications

Maternal perinatal anxiety and infant primary care use in 1998–2016: a UK cohort study

Characteristics, risk factors and clinical impact of penicillin and other antibiotic allergies in adults in the UK General Practice: a population-based cohort study

Glucose Lowering through Weight management (GLoW): a randomised controlled trial of the clinical and cost effectiveness of a diabetes education and behavioural weight management programme vs a diabetes education programme in adults with a recent diagnosis of type 2 diabetes